25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biovica International AB (publ)
Buy, Hold or Sell?

Let's analyze Biovica together

I guess you are interested in Biovica International AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biovica International AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biovica International AB (publ)

I send you an email if I find something interesting about Biovica International AB (publ).

1. Quick Overview

1.1. Quick analysis of Biovica (30 sec.)










1.2. What can you expect buying and holding a share of Biovica? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.98
Expected worth in 1 year
kr0.79
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
kr-0.19
Return On Investment
-10.0%

For what price can you sell your share?

Current Price per Share
kr1.87
Expected price per share
kr1.494 - kr2
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biovica (5 min.)




Live pricePrice per Share (EOD)
kr1.87
Intrinsic Value Per Share
kr-15.74 - kr-18.51
Total Value Per Share
kr-14.76 - kr-17.53

2.2. Growth of Biovica (5 min.)




Is Biovica growing?

Current yearPrevious yearGrowGrow %
How rich?$8.1m$11.4m-$2.2m-24.9%

How much money is Biovica making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$2.7m$142.9k5.5%
Net Profit Margin-1,740.7%-3,222.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Biovica (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biovica?

Welcome investor! Biovica's management wants to use your money to grow the business. In return you get a share of Biovica.

First you should know what it really means to hold a share of Biovica. And how you can make/lose money.

Speculation

The Price per Share of Biovica is kr1.868. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.98. Based on the TTM, the Book Value Change Per Share is kr-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovica.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.02-1.2%-0.03-1.5%-0.03-1.6%-0.02-1.0%-0.01-0.7%
Usd Book Value Change Per Share-0.01-0.4%0.00-0.2%0.000.0%0.000.0%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.4%0.00-0.2%0.000.0%0.000.0%0.000.1%
Usd Price Per Share0.27-0.22-0.76-1.94-1.35-
Price to Earnings Ratio-2.95--2.07--6.58--39.71--35.91-
Price-to-Total Gains Ratio-36.97--11.32--17.51--146.57--149.82-
Price to Book Ratio3.02-2.27-6.67-14.96-12.01-
Price-to-Total Gains Ratio-36.97--11.32--17.51--146.57--149.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1694276
Number of shares5902
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (5902 shares)-25.06-3.91
Gains per Year (5902 shares)-100.25-15.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-100-1100-16-26
20-201-2100-31-42
30-301-3100-47-58
40-401-4100-63-74
50-501-5100-78-90
60-602-6100-94-106
70-702-7100-110-122
80-802-8100-125-138
90-902-9100-141-154
100-1003-10100-156-170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.036.00.00.0%0.036.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%8.025.03.022.2%8.025.03.022.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%0.00.036.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%8.025.03.022.2%8.025.03.022.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biovica International AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.080-0.047-41%0.007-1208%-0.007-91%0.027-394%
Book Value Per Share--0.9761.101-11%1.375-29%1.376-29%1.047-7%
Current Ratio--3.5574.417-19%5.337-33%9.618-63%7.771-54%
Debt To Asset Ratio--0.2160.211+2%0.195+10%0.142+52%0.116+86%
Debt To Equity Ratio--0.2750.271+1%0.245+12%0.173+59%0.138+100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.250-0.315+26%-0.333+33%-0.209-17%-0.136-46%
Free Cash Flow Per Share---0.317-0.288-9%-0.324+2%-0.191-40%-0.125-60%
Free Cash Flow To Equity Per Share---0.156-0.029-82%0.007-2336%0.005-3555%0.031-599%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---18.510--------
Intrinsic Value_10Y_min---15.736--------
Intrinsic Value_1Y_max---1.146--------
Intrinsic Value_1Y_min---1.125--------
Intrinsic Value_3Y_max---3.983--------
Intrinsic Value_3Y_min---3.792--------
Intrinsic Value_5Y_max---7.472--------
Intrinsic Value_5Y_min---6.889--------
Market Cap170950214.272-58%269969556.800220299734.104+23%767811722.560-65%1957915316.773-86%1363496244.927-80%
Net Profit Margin---13.354-17.407+30%-32.229+141%-39.556+196%-34.933+162%
Operating Margin---13.632-17.519+29%-32.231+136%-39.835+192%-35.053+157%
Operating Ratio--14.74724.590-40%33.396-56%45.178-67%38.790-62%
Pb Ratio1.914-58%3.0222.272+33%6.668-55%14.956-80%12.007-75%
Pe Ratio-1.867+37%-2.949-2.065-30%-6.584+123%-39.711+1247%-35.912+1118%
Price Per Share1.868-58%2.9502.407+23%8.390-65%21.394-86%14.899-80%
Price To Free Cash Flow Ratio-1.471+37%-2.324-2.095-10%-6.738+190%-45.690+1866%-42.008+1708%
Price To Total Gains Ratio-23.408+37%-36.967-11.319-69%-17.506-53%-146.570+296%-149.816+305%
Quick Ratio--3.4664.405-21%5.380-36%9.565-64%7.684-55%
Return On Assets---0.201-0.230+15%-0.204+1%-0.139-31%-0.105-48%
Return On Equity---0.256-0.296+15%-0.2550%-0.169-34%-0.128-50%
Total Gains Per Share---0.080-0.047-41%0.007-1208%-0.007-91%0.027-394%
Usd Book Value--8102956.6009138546.502-11%11412531.575-29%11419275.115-29%8692917.267-7%
Usd Book Value Change Per Share---0.007-0.004-41%0.001-1208%-0.001-91%0.002-394%
Usd Book Value Per Share--0.0890.100-11%0.125-29%0.125-29%0.095-7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.023-0.029+26%-0.030+33%-0.019-17%-0.012-46%
Usd Free Cash Flow---2634290.800-2393074.150-9%-2693291.150+2%-1585730.775-40%-1040665.346-60%
Usd Free Cash Flow Per Share---0.029-0.026-9%-0.029+2%-0.017-40%-0.011-60%
Usd Free Cash Flow To Equity Per Share---0.014-0.003-82%0.001-2336%0.000-3555%0.003-599%
Usd Market Cap15505184.434-58%24486238.80219981185.883+23%69640523.236-65%177582919.231-86%123669109.415-80%
Usd Price Per Share0.169-58%0.2680.218+23%0.761-65%1.940-86%1.351-80%
Usd Profit---2076032.300-2617783.400+26%-2760703.925+33%-1732097.900-17%-1128042.199-46%
Usd Revenue--155459.800164416.425-5%104146.275+49%88006.210+77%78953.090+97%
Usd Total Gains Per Share---0.007-0.004-41%0.001-1208%-0.001-91%0.002-394%
 EOD+3 -5MRQTTM+13 -20YOY+13 -205Y+7 -2610Y+7 -26

3.3 Fundamental Score

Let's check the fundamental score of Biovica International AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.867
Price to Book Ratio (EOD)Between0-11.914
Net Profit Margin (MRQ)Greater than0-13.354
Operating Margin (MRQ)Greater than0-13.632
Quick Ratio (MRQ)Greater than13.466
Current Ratio (MRQ)Greater than13.557
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.15-0.256
Return on Assets (MRQ)Greater than0.05-0.201
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Biovica International AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.564
Ma 20Greater thanMa 501.941
Ma 50Greater thanMa 1002.250
Ma 100Greater thanMa 2002.461
OpenGreater thanClose1.742
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biovica International AB (publ)

Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America. It primarily focuses on breast cancer. The company develops DiviTum TKa, a blood-based biomarker assay that measures thymidine kinase activity, which is correlated with cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. Biovica International AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-11-14 17:31:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biovica earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • A Net Profit Margin of -1,335.4% means that kr-13.35 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovica International AB (publ):

  • The MRQ is -1,335.4%. The company is making a huge loss. -2
  • The TTM is -1,740.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,335.4%TTM-1,740.7%+405.3%
TTM-1,740.7%YOY-3,222.9%+1,482.2%
TTM-1,740.7%5Y-3,955.6%+2,214.9%
5Y-3,955.6%10Y-3,493.3%-462.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,335.4%-120.2%-1,215.2%
TTM-1,740.7%-210.7%-1,530.0%
YOY-3,222.9%-219.8%-3,003.1%
5Y-3,955.6%-348.0%-3,607.6%
10Y-3,493.3%-473.2%-3,020.1%
4.3.1.2. Return on Assets

Shows how efficient Biovica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • -20.1% Return on Assets means that Biovica generated kr-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovica International AB (publ):

  • The MRQ is -20.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.1%TTM-23.0%+2.9%
TTM-23.0%YOY-20.4%-2.7%
TTM-23.0%5Y-13.9%-9.1%
5Y-13.9%10Y-10.5%-3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.1%-11.0%-9.1%
TTM-23.0%-11.8%-11.2%
YOY-20.4%-11.3%-9.1%
5Y-13.9%-12.6%-1.3%
10Y-10.5%-14.3%+3.8%
4.3.1.3. Return on Equity

Shows how efficient Biovica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • -25.6% Return on Equity means Biovica generated kr-0.26 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovica International AB (publ):

  • The MRQ is -25.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.6%TTM-29.6%+4.0%
TTM-29.6%YOY-25.5%-4.1%
TTM-29.6%5Y-16.9%-12.6%
5Y-16.9%10Y-12.8%-4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.6%-14.1%-11.5%
TTM-29.6%-15.8%-13.8%
YOY-25.5%-13.9%-11.6%
5Y-16.9%-18.5%+1.6%
10Y-12.8%-19.2%+6.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biovica International AB (publ).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biovica is operating .

  • Measures how much profit Biovica makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • An Operating Margin of -1,363.2% means the company generated kr-13.63  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovica International AB (publ):

  • The MRQ is -1,363.2%. The company is operating very inefficient. -2
  • The TTM is -1,751.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,363.2%TTM-1,751.9%+388.6%
TTM-1,751.9%YOY-3,223.1%+1,471.2%
TTM-1,751.9%5Y-3,983.5%+2,231.6%
5Y-3,983.5%10Y-3,505.3%-478.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,363.2%-267.8%-1,095.4%
TTM-1,751.9%-313.4%-1,438.5%
YOY-3,223.1%-224.0%-2,999.1%
5Y-3,983.5%-385.5%-3,598.0%
10Y-3,505.3%-498.7%-3,006.6%
4.3.2.2. Operating Ratio

Measures how efficient Biovica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 14.75 means that the operating costs are kr14.75 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Biovica International AB (publ):

  • The MRQ is 14.747. The company is inefficient in keeping operating costs low. -1
  • The TTM is 24.590. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.747TTM24.590-9.842
TTM24.590YOY33.396-8.806
TTM24.5905Y45.178-20.588
5Y45.17810Y38.790+6.388
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7472.631+12.116
TTM24.5903.412+21.178
YOY33.3963.299+30.097
5Y45.1784.788+40.390
10Y38.7906.538+32.252
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biovica International AB (publ).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biovica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.56 means the company has kr3.56 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovica International AB (publ):

  • The MRQ is 3.557. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.417. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.557TTM4.417-0.860
TTM4.417YOY5.337-0.920
TTM4.4175Y9.618-5.201
5Y9.61810Y7.771+1.848
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5573.690-0.133
TTM4.4173.875+0.542
YOY5.3374.684+0.653
5Y9.6185.946+3.672
10Y7.7716.274+1.497
4.4.3.2. Quick Ratio

Measures if Biovica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • A Quick Ratio of 3.47 means the company can pay off kr3.47 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovica International AB (publ):

  • The MRQ is 3.466. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.405. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.466TTM4.405-0.939
TTM4.405YOY5.380-0.976
TTM4.4055Y9.565-5.160
5Y9.56510Y7.684+1.881
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4663.122+0.344
TTM4.4053.451+0.954
YOY5.3804.498+0.882
5Y9.5655.922+3.643
10Y7.6846.414+1.270
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biovica International AB (publ).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biovica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biovica to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Biovica assets are financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biovica International AB (publ):

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.211. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.211+0.005
TTM0.211YOY0.195+0.016
TTM0.2115Y0.142+0.069
5Y0.14210Y0.116+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.353-0.137
TTM0.2110.350-0.139
YOY0.1950.311-0.116
5Y0.1420.367-0.225
10Y0.1160.382-0.266
4.5.4.2. Debt to Equity Ratio

Measures if Biovica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biovica to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.5% means that company has kr0.28 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovica International AB (publ):

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.271. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.271+0.004
TTM0.271YOY0.245+0.026
TTM0.2715Y0.173+0.098
5Y0.17310Y0.138+0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.393-0.118
TTM0.2710.435-0.164
YOY0.2450.378-0.133
5Y0.1730.451-0.278
10Y0.1380.493-0.355
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biovica generates.

  • Above 15 is considered overpriced but always compare Biovica to the Biotechnology industry mean.
  • A PE ratio of -2.95 means the investor is paying kr-2.95 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovica International AB (publ):

  • The EOD is -1.867. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.949. Based on the earnings, the company is expensive. -2
  • The TTM is -2.065. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.867MRQ-2.949+1.082
MRQ-2.949TTM-2.065-0.884
TTM-2.065YOY-6.584+4.519
TTM-2.0655Y-39.711+37.646
5Y-39.71110Y-35.912-3.799
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.867-2.126+0.259
MRQ-2.949-2.454-0.495
TTM-2.065-3.147+1.082
YOY-6.584-3.335-3.249
5Y-39.711-6.070-33.641
10Y-35.912-6.597-29.315
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovica International AB (publ):

  • The EOD is -1.471. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.324. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.095. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.471MRQ-2.324+0.852
MRQ-2.324TTM-2.095-0.229
TTM-2.095YOY-6.738+4.643
TTM-2.0955Y-45.690+43.595
5Y-45.69010Y-42.008-3.682
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.471-2.981+1.510
MRQ-2.324-3.363+1.039
TTM-2.095-3.667+1.572
YOY-6.738-4.535-2.203
5Y-45.690-8.343-37.347
10Y-42.008-9.276-32.732
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biovica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.02 means the investor is paying kr3.02 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovica International AB (publ):

  • The EOD is 1.914. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.022. Based on the equity, the company is fair priced.
  • The TTM is 2.272. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.914MRQ3.022-1.108
MRQ3.022TTM2.272+0.750
TTM2.272YOY6.668-4.396
TTM2.2725Y14.956-12.684
5Y14.95610Y12.007+2.950
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9141.863+0.051
MRQ3.0222.028+0.994
TTM2.2722.339-0.067
YOY6.6682.391+4.277
5Y14.9563.666+11.290
10Y12.0074.360+7.647
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-07-312023-10-312024-01-312024-04-302024-07-31
Total Other Income Expense Net 2451,2991,544-1,281263381644-1,267-623



6.2. Latest Balance Sheet

Balance Sheet of 2024-07-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets113,921
Total Liabilities24,583
Total Stockholder Equity89,338
 As reported
Total Liabilities 24,583
Total Stockholder Equity+ 89,338
Total Assets = 113,921

Assets

Total Assets113,921
Total Current Assets73,282
Long-term Assets40,640
Total Current Assets
Cash And Cash Equivalents 65,209
Net Receivables 6,196
Inventory 1,877
Total Current Assets  (as reported)73,282
Total Current Assets  (calculated)73,282
+/-0
Long-term Assets
Property Plant Equipment 7,106
Intangible Assets 30,148
Long-term Assets Other 441
Long-term Assets  (as reported)40,640
Long-term Assets  (calculated)37,695
+/- 2,945

Liabilities & Shareholders' Equity

Total Current Liabilities20,602
Long-term Liabilities3,981
Total Stockholder Equity89,338
Total Current Liabilities
Short-term Debt 3,500
Accounts payable 3,469
Other Current Liabilities -1,710
Total Current Liabilities  (as reported)20,602
Total Current Liabilities  (calculated)5,259
+/- 15,343
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,439
Long-term Liabilities  (as reported)3,981
Long-term Liabilities  (calculated)3,439
+/- 542
Total Stockholder Equity
Common Stock6,023
Retained Earnings -476,180
Accumulated Other Comprehensive Income 316
Other Stockholders Equity 559,179
Total Stockholder Equity (as reported)89,338
Total Stockholder Equity (calculated)89,338
+/-0
Other
Capital Stock6,023
Cash and Short Term Investments 65,209
Common Stock Shares Outstanding 84,056
Current Deferred Revenue11,759
Liabilities and Stockholders Equity 113,921
Net Debt -58,270
Net Invested Capital 89,338
Net Working Capital 52,680
Property Plant and Equipment Gross 7,106
Short Long Term Debt Total 6,939



6.3. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-07-31
> Total Assets 
0
28,733
28,733
0
51,819
0
97,184
92,925
88,275
83,217
80,771
75,741
70,291
65,055
60,860
111,633
108,237
101,062
90,260
80,989
212,313
205,520
192,650
177,953
165,020
154,479
151,631
132,106
107,715
204,515
172,288
134,402
104,222
158,320
131,408
113,921
113,921131,408158,320104,222134,402172,288204,515107,715132,106151,631154,479165,020177,953192,650205,520212,31380,98990,260101,062108,237111,63360,86065,05570,29175,74180,77183,21788,27592,92597,184051,819028,73328,7330
   > Total Current Assets 
1,047
1,966
1,966
867
23,728
0
66,645
61,825
55,935
48,771
44,377
38,663
32,308
25,949
20,035
70,351
61,696
53,600
42,303
32,464
164,373
158,976
147,266
133,474
121,040
111,438
94,914
76,312
52,744
151,182
119,990
84,411
55,897
113,006
88,116
73,282
73,28288,116113,00655,89784,411119,990151,18252,74476,31294,914111,438121,040133,474147,266158,976164,37332,46442,30353,60061,69670,35120,03525,94932,30838,66344,37748,77155,93561,82566,645023,7288671,9661,9661,047
       Cash And Cash Equivalents 
-1,047
867
867
-867
22,515
0
65,410
60,895
55,040
47,299
42,127
37,642
31,268
24,203
16,831
68,207
58,876
51,623
40,777
31,394
162,411
155,266
145,351
130,927
117,937
108,171
77,413
71,705
46,997
145,150
114,327
75,702
46,932
105,238
66,565
65,209
65,20966,565105,23846,93275,702114,327145,15046,99771,70577,413108,171117,937130,927145,351155,266162,41131,39440,77751,62358,87668,20716,83124,20331,26837,64242,12747,29955,04060,89565,410022,515-867867867-1,047
       Short-term Investments 
2,093
0
0
1,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
12,377
0
0
0
12,205
0
0
0
12,842
0
012,84200012,20500012,377000120000000000000000001,734002,093
       Net Receivables 
0
0
0
0
266
0
929
584
554
1,062
1,068
179
4
1,226
2,757
320
1,504
285
0
524
1,282
1,745
1,375
2,095
1,992
2,160
3,590
2,994
4,332
4,715
4,304
6,441
6,472
5,135
6,510
6,196
6,1966,5105,1356,4726,4414,3044,7154,3322,9943,5902,1601,9922,0951,3751,7451,28252402851,5043202,7571,22641791,0681,06255458492902660000
       Other Current Assets 
0
616
616
0
865
0
-1
1
554
1,062
1,847
683
710
1
1
1,615
2,548
1,220
1,129
-1
-1
2,849
1
2,095
1
-1
2
-1
1
4,131
1
-1
4,010
125
-1
4,935
4,935-11254,010-114,1311-12-112,09512,849-1-11,1291,2202,5481,615117106831,8471,0625541-1086506166160
   > Long-term Assets 
-1,047
26,767
26,767
-867
28,090
0
30,539
31,101
32,340
34,446
36,394
37,078
37,982
39,106
40,825
41,282
46,541
47,462
47,955
48,525
47,938
46,544
45,384
44,479
43,980
43,040
56,717
55,794
54,970
53,332
52,298
49,991
48,324
45,314
43,292
40,640
40,64043,29245,31448,32449,99152,29853,33254,97055,79456,71743,04043,98044,47945,38446,54447,93848,52547,95547,46246,54141,28240,82539,10637,98237,07836,39434,44632,34031,10130,539028,090-86726,76726,767-1,047
       Property Plant Equipment 
0
216
216
0
186
0
995
935
1,155
2,239
2,616
2,732
2,550
2,542
2,918
2,586
5,512
5,047
4,546
4,092
3,915
3,463
3,015
2,446
2,478
2,079
13,638
13,509
13,486
12,128
11,210
10,484
9,912
8,625
8,114
7,106
7,1068,1148,6259,91210,48411,21012,12813,48613,50913,6382,0792,4782,4463,0153,4633,9154,0924,5465,0475,5122,5862,9182,5422,5502,7322,6162,2391,155935995018602162160
       Goodwill 
0
0
0
0
0
0
6,926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000006,926000000
       Intangible Assets 
0
1,238
18,483
0
19,737
0
22,414
29,984
31,014
32,054
33,778
34,346
35,432
36,577
37,907
38,696
40,138
41,601
42,667
43,756
43,373
42,496
41,869
41,626
41,148
40,663
40,353
39,672
38,936
38,177
37,419
35,965
34,511
33,057
31,602
30,148
30,14831,60233,05734,51135,96537,41938,17738,93639,67240,35340,66341,14841,62641,86942,49643,37343,75642,66741,60140,13838,69637,90736,57735,43234,34633,77832,05431,01429,98422,414019,737018,4831,2380
       Long-term Assets Other 
-1,047
17,265
8,068
-867
8,167
0
204
182
171
153
0
0
0
-13
0
0
-1
814
-1
677
651
1
1
-44,072
-43,626
-42,742
-2
1
-2
-50,305
1
-46,449
-1
425
0
441
4410425-1-46,4491-50,305-21-2-42,742-43,626-44,07211651677-1814-100-1300015317118220408,167-8678,06817,265-1,047
> Total Liabilities 
0
3,996
3,254
0
3,767
0
5,638
4,876
4,878
5,937
7,058
6,115
6,230
7,037
8,762
8,921
11,697
12,038
12,042
11,154
9,807
10,873
9,989
7,501
8,103
11,508
27,543
28,265
25,927
28,107
33,652
27,925
23,208
22,290
34,767
24,583
24,58334,76722,29023,20827,92533,65228,10725,92728,26527,54311,5088,1037,5019,98910,8739,80711,15412,04212,03811,6978,9218,7627,0376,2306,1157,0585,9374,8784,8765,63803,76703,2543,9960
   > Total Current Liabilities 
0
3,996
3,062
0
3,575
0
5,538
4,776
4,778
5,836
6,672
5,518
5,658
6,466
7,822
8,163
8,181
2,468
9,061
8,797
7,445
8,851
8,595
6,446
7,017
10,741
16,094
17,612
16,034
17,949
23,638
18,519
15,016
15,535
28,291
20,602
20,60228,29115,53515,01618,51923,63817,94916,03417,61216,09410,7417,0176,4468,5958,8517,4458,7979,0612,4688,1818,1637,8226,4665,6585,5186,6725,8364,7784,7765,53803,57503,0623,9960
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,182
1,431
1,310
1,255
1,486
1,295
1,354
1,350
4,464
4,532
4,819
3,097
3,149
3,212
3,524
3,416
3,532
3,500
3,5003,5323,4163,5243,2123,1493,0974,8194,5324,4641,3501,3541,2951,4861,2551,3101,4311,182000000000000000000
       Accounts payable 
0
1,406
1,406
0
1,032
0
1,326
0
0
0
1,009
0
0
0
860
2,492
0
0
1,007
229
2,332
1,800
1,085
929
512
2,075
2,888
3,673
3,426
3,678
3,277
1,906
4,666
4,137
3,028
3,469
3,4693,0284,1374,6661,9063,2773,6783,4263,6732,8882,0755129291,0851,8002,3322291,007002,4928600001,0090001,32601,03201,4061,4060
       Other Current Liabilities 
0
2,590
1,656
0
2,543
0
4,212
4,776
4,778
5,836
5,663
5,518
5,658
6,466
6,962
5,671
8,181
2,468
623
805
1,056
779
634
691
709
727
621
417
333
1,043
985
996
-4,240
-3,649
18,455
-1,710
-1,71018,455-3,649-4,2409969851,0433334176217277096916347791,0568056232,4688,1815,6716,9626,4665,6585,5185,6635,8364,7784,7764,21202,54301,6562,5900
   > Long-term Liabilities 
0
0
192
0
192
0
100
100
100
101
386
597
572
571
940
758
3,516
9,570
2,981
2,357
2,362
2,022
1,394
1,055
1,086
767
11,449
10,653
9,893
10,158
10,014
9,406
8,192
6,755
6,476
3,981
3,9816,4766,7558,1929,40610,01410,1589,89310,65311,4497671,0861,0551,3942,0222,3622,3572,9819,5703,5167589405715725973861011001001000192019200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,729
1,475
934
687
778
513
8,783
8,153
7,563
7,993
7,304
6,628
0
0
0
0
00006,6287,3047,9937,5638,1538,7835137786879341,4751,72900000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
758
1,184
7,320
709
641
633
547
460
368
308
254
2,666
2,500
2,330
2,165
2,710
2,778
0
0
0
0
00002,7782,7102,1652,3302,5002,6662543083684605476336417097,3201,184758000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,296
0
0
0
37,476
0
0
0
36,691
0
0
0
34,488
0
0
0
0
0
0000034,48800036,69100037,47600037,296000000000000000000
> Total Stockholder Equity
8,316
24,545
25,479
24,545
48,052
0
91,546
88,049
83,397
77,280
73,713
69,626
64,061
58,018
52,098
102,712
96,540
89,025
78,218
69,835
202,506
194,648
182,661
170,452
156,916
142,970
124,089
103,841
81,789
176,407
138,635
106,476
81,013
136,029
96,641
89,338
89,33896,641136,02981,013106,476138,635176,40781,789103,841124,089142,970156,916170,452182,661194,648202,50669,83578,21889,02596,540102,71252,09858,01864,06169,62673,71377,28083,39788,04991,546048,05224,54525,47924,5458,316
   Common Stock
0
559
559
0
852
0
1,172
1,172
1,172
1,172
1,172
1,172
1,172
1,172
1,172
1,572
1,572
1,572
1,572
1,572
1,885
1,895
1,895
1,895
1,898
1,899
1,899
1,902
1,906
3,049
3,049
3,049
3,049
5,604
5,604
6,023
6,0235,6045,6043,0493,0493,0493,0491,9061,9021,8991,8991,8981,8951,8951,8951,8851,5721,5721,5721,5721,5721,1721,1721,1721,1721,1721,1721,1721,1721,172085205595590
   Retained Earnings Total Equity000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
8,316
62
62
24,545
0
0
0
6,463
8,238
10,023
0
0
0
0
-1
0
0
-1
1
0
-2
-1
-20
5
-9
-48
116
155
290
177
117
221
443
186
410
316
316410186443221117177290155116-48-95-20-1-201-100-1000010,0238,2386,46300024,54562628,316
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
176,662
195,133
195,133
335,719
338,744
338,758
338,758
339,624
340,006
340,049
340,764
341,822
463,949
463,938
463,938
0
0
0
0
0000463,938463,938463,949341,822340,764340,049340,006339,624338,758338,758338,744335,719195,133195,133176,66200000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
0
57,422
57,422
0
84,638
0
138,514
88,049
83,397
77,280
133,776
133,776
133,776
133,776
133,776
190,058
176,868
176,662
195,132
195,133
335,719
338,744
338,758
168,306
182,699
196,988
216,075
340,764
341,822
463,949
463,937
357,683
463,938
543,999
543,918
559,179
559,179543,918543,999463,938357,683463,937463,949341,822340,764216,075196,988182,699168,306338,758338,744335,719195,133195,132176,662176,868190,058133,776133,776133,776133,776133,77677,28083,39788,049138,514084,638057,42257,4220



6.4. Balance Sheets

Currency in SEK. All numbers in thousands.




6.5. Cash Flows

Currency in SEK. All numbers in thousands.




6.6. Income Statements

Currency in SEK. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-04-30. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,290
Cost of Revenue-128,275
Gross Profit-120,985-120,985
 
Operating Income (+$)
Gross Profit-120,985
Operating Expense-5,088
Operating Income-126,073-126,073
 
Operating Expense (+$)
Research Development5,088
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense5,0885,088
 
Net Interest Income (+$)
Interest Income1,159
Interest Expense-4
Other Finance Cost-285
Net Interest Income870
 
Pretax Income (+$)
Operating Income-126,073
Net Interest Income870
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-124,136-128,010
EBIT - interestExpense = -126,077
-124,136
-124,819
Interest Expense4
Earnings Before Interest and Taxes (EBIT)-126,073-124,132
Earnings Before Interest and Taxes (EBITDA)-121,732
 
After tax Income (+$)
Income Before Tax-124,136
Tax Provision-687
Net Income From Continuing Ops-124,823-124,823
Net Income-124,823
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses133,363
Total Other Income/Expenses Net1,937-870
 

Technical Analysis of Biovica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biovica. The general trend of Biovica is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biovica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biovica International AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.914 < 1.95 < 2.

The bearish price targets are: 1.564 > 1.5 > 1.494.

Tweet this
Biovica International AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biovica International AB (publ). The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biovica International AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biovica International AB (publ). The current macd is -0.13071424.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovica price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biovica. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biovica price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biovica International AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartBiovica International AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biovica International AB (publ). The current adx is 24.26.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biovica shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biovica International AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biovica International AB (publ). The current sar is 2.1289184.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biovica International AB (publ) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biovica International AB (publ). The current rsi is 44.56. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biovica International AB (publ) Daily Relative Strength Index (RSI) ChartBiovica International AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biovica International AB (publ). The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovica price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biovica International AB (publ) Daily Stochastic Oscillator ChartBiovica International AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biovica International AB (publ). The current cci is -36.61205102.

Biovica International AB (publ) Daily Commodity Channel Index (CCI) ChartBiovica International AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biovica International AB (publ). The current cmo is -4.49693503.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biovica International AB (publ) Daily Chande Momentum Oscillator (CMO) ChartBiovica International AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biovica International AB (publ). The current willr is -45.32374101.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biovica is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biovica International AB (publ) Daily Williams %R ChartBiovica International AB (publ) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biovica International AB (publ).

Biovica International AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biovica International AB (publ). The current atr is 0.22486166.

Biovica International AB (publ) Daily Average True Range (ATR) ChartBiovica International AB (publ) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biovica International AB (publ). The current obv is 1,130,672.

Biovica International AB (publ) Daily On-Balance Volume (OBV) ChartBiovica International AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biovica International AB (publ). The current mfi is 24.27.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biovica International AB (publ) Daily Money Flow Index (MFI) ChartBiovica International AB (publ) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biovica International AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Biovica International AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biovica International AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.564
Ma 20Greater thanMa 501.941
Ma 50Greater thanMa 1002.250
Ma 100Greater thanMa 2002.461
OpenGreater thanClose1.742
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biovica with someone you think should read this too:
  • Are you bullish or bearish on Biovica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biovica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biovica International AB (publ)

I send you an email if I find something interesting about Biovica International AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about Biovica International AB (publ).

Receive notifications about Biovica International AB (publ) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.